Search research articles
Contact Us
Filters
Showing results (1081-1090 of 1,433) with videos related to
Page
of 144
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
July 5, 2016
5-hydroxytryptamine and Lyme disease. Opportunity for a novel therapy to reduce the cerebellar tremor?
G K Maximov, K G Maximov, A A Chokoeva, et al.
Neuroendocrinology
|
June 26, 2020
Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms
Giovanni Guarneri, Louis de Mestier, Luca Landoni, et al.
Plos One
|
September 7, 2012
Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome
Lorenza Pastorino, Annamaria Pollio, Giovanni Pellacani, et al.
Frontiers in Immunology
|
February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis
Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Medicina (Kaunas, Lithuania)
|
December 23, 2022
Vascular Diameter as Clue for the Diagnosis of Clinically and/or Dermoscopically Equivocal Pigmented and Non-Pigmented Basal Cell Carcinomas and Nodular Melanomas
Roberta Giuffrida, Claudio Conforti, Andreas Blum, et al.
Annals of Surgical Oncology
|
February 9, 2011
Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer
Valentina Guarneri, Annarita Pecchi, Federico Piacentini, et al.
Clinical Breast Cancer
|
October 28, 2008
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278)
Valentina Guarneri, Antonio Frassoldati, Paolo Bruzzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 26, 2022
Event-free survival after <sup>68</sup> Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
Francesco Ceci, Guido Rovera, Giuseppe Carlo Iorio, et al.
Critical Reviews in Oncology/Hematology
|
August 17, 2025
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC
Daniela Scattolin, Frank W J Heijboer, Jules L Derks, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 11, 2024
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome
Michele Bottosso, Renata L Sandoval, Benjamin Verret, et al.
Page
of 144
Search research articles
Search
Showing results (1081-1090 of 1,433) with videos related to
Sort By:
Page
of 144
Journal of Biological Regulators and Homeostatic Agents
|
July 5, 2016
5-hydroxytryptamine and Lyme disease. Opportunity for a novel therapy to reduce the cerebellar tremor?
G K Maximov, K G Maximov, A A Chokoeva, et al.
Neuroendocrinology
|
June 26, 2020
Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms
Giovanni Guarneri, Louis de Mestier, Luca Landoni, et al.
Plos One
|
September 7, 2012
Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome
Lorenza Pastorino, Annamaria Pollio, Giovanni Pellacani, et al.
Frontiers in Immunology
|
February 7, 2024
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis
Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, et al.
Medicina (Kaunas, Lithuania)
|
December 23, 2022
Vascular Diameter as Clue for the Diagnosis of Clinically and/or Dermoscopically Equivocal Pigmented and Non-Pigmented Basal Cell Carcinomas and Nodular Melanomas
Roberta Giuffrida, Claudio Conforti, Andreas Blum, et al.
Annals of Surgical Oncology
|
February 9, 2011
Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer
Valentina Guarneri, Annarita Pecchi, Federico Piacentini, et al.
Clinical Breast Cancer
|
October 28, 2008
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278)
Valentina Guarneri, Antonio Frassoldati, Paolo Bruzzi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 26, 2022
Event-free survival after <sup>68</sup> Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
Francesco Ceci, Guido Rovera, Giuseppe Carlo Iorio, et al.
Critical Reviews in Oncology/Hematology
|
August 17, 2025
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC
Daniela Scattolin, Frank W J Heijboer, Jules L Derks, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 11, 2024
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome
Michele Bottosso, Renata L Sandoval, Benjamin Verret, et al.
Page
of 144